Phase 2 trial of crizotinib in Japanese patients with advanced NSCLC harboring a MET gene alteration: a Co-MET study.

Kaname NosakiKiyotaka YohRyo ToyozawaHidehito HorinouchiMasahiro MoriseKadoaki OhashiHaruyasu MurakamiMiyako SatouchiJun Sakakibara-KonishiSeiji YanoFumihiko OkumuraShingo MatsumotoMototsugu ShimokawaTakashi SetoKoichi Goto

Published in: International journal of clinical oncology (2024)

UMIN000031623.

Keyphrases

advanced non small cell lung cancer
tyrosine kinase
small cell lung cancer
gene expression
epidermal growth factor receptor
transcription factor
genome wide identification